Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
British Journal of Clinical Pharmacology
|
September 4, 2007
The contribution of observational studies to the knowledge of drug effectiveness in heart failure
Daniela Dobre, Dirk J van Veldhuisen, Mike J L DeJongste, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2008
Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system
Larissa Grigoryan, Johannes G M Burgerhof, John E Degener, et al.
Pharmacoepidemiology and Drug Safety
|
September 20, 2007
Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study
Larissa Grigoryan, Johannes G M Burgerhof, John E Degener, et al.
Quality & Safety in Health Care
|
December 7, 2007
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
Samuel Coenen, Matus Ferech, Flora M Haaijer-Ruskamp, et al.
British Journal of Clinical Pharmacology
|
December 4, 2014
Understanding drug preferences, different perspectives
Peter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Drug Safety
|
October 11, 2011
Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands
Aileen B Dequito, Peter G M Mol, Jasperien E van Doormaal, et al.
Drug Safety
|
April 7, 2012
Impact of safety-related regulatory action on clinical practice: a systematic review
Sigrid Piening, Flora M Haaijer-Ruskamp, Jonie T N de Vries, et al.
Journal of Evaluation in Clinical Practice
|
June 16, 2010
Computerized physician order entry (CPOE) system: expectations and experiences of users
Jasperien E van Doormaal, Peter G M Mol, Rianne J Zaal, et al.
Pharmacoepidemiology and Drug Safety
|
March 15, 2008
Reliability of the assessment of preventable adverse drug events in daily clinical practice
Jasperien E van Doormaal, Peter G M Mol, Patricia M L A van den Bemt, et al.
Drug Safety
|
September 20, 2013
Post-approval safety issues with innovative drugs: a European cohort study
Peter G M Mol, Arna H Arnardottir, Domenico Motola, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
British Journal of Clinical Pharmacology
|
September 4, 2007
The contribution of observational studies to the knowledge of drug effectiveness in heart failure
Daniela Dobre, Dirk J van Veldhuisen, Mike J L DeJongste, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2008
Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system
Larissa Grigoryan, Johannes G M Burgerhof, John E Degener, et al.
Pharmacoepidemiology and Drug Safety
|
September 20, 2007
Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study
Larissa Grigoryan, Johannes G M Burgerhof, John E Degener, et al.
Quality & Safety in Health Care
|
December 7, 2007
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
Samuel Coenen, Matus Ferech, Flora M Haaijer-Ruskamp, et al.
British Journal of Clinical Pharmacology
|
December 4, 2014
Understanding drug preferences, different perspectives
Peter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Drug Safety
|
October 11, 2011
Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands
Aileen B Dequito, Peter G M Mol, Jasperien E van Doormaal, et al.
Drug Safety
|
April 7, 2012
Impact of safety-related regulatory action on clinical practice: a systematic review
Sigrid Piening, Flora M Haaijer-Ruskamp, Jonie T N de Vries, et al.
Journal of Evaluation in Clinical Practice
|
June 16, 2010
Computerized physician order entry (CPOE) system: expectations and experiences of users
Jasperien E van Doormaal, Peter G M Mol, Rianne J Zaal, et al.
Pharmacoepidemiology and Drug Safety
|
March 15, 2008
Reliability of the assessment of preventable adverse drug events in daily clinical practice
Jasperien E van Doormaal, Peter G M Mol, Patricia M L A van den Bemt, et al.
Drug Safety
|
September 20, 2013
Post-approval safety issues with innovative drugs: a European cohort study
Peter G M Mol, Arna H Arnardottir, Domenico Motola, et al.
Page
of 10